These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38437)

  • 21. [Clinical and experimental evaluation of osteotropic radiopharmaceutical preparations].
    Korsunskiĭ VN; Tarasov NF; Koval'chuk ND; Levin VI; Boldyrev PP
    Med Radiol (Mosk); 1980 Sep; 25(9):9-13. PubMed ID: 6252408
    [No Abstract]   [Full Text] [Related]  

  • 22. Skeletal uptake of pyrophosphate labeled with technetium-95m and technetium-96, as evaluated by autoradiography.
    Guillemart A; Besnard JC; Le Pape A; Galy G; Fetissoff F
    J Nucl Med; 1978 Aug; 19(8):895-9. PubMed ID: 210266
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacodynamics of stannous chelates administered with 99mTc-labeled chelates.
    Dewanjee MK; Wahner HW
    Radiology; 1979 Sep; 132(3):711-716. PubMed ID: 224413
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemistry of 99mTc tracers. II. In vitro conversion of tagged HEDP and pyrophosphate (bone-seekers) into gluconate (renal agent). Effects of Ca and Fe (ii) on in vivo distribution.
    McRae J; Hambright P; Valk P; Bearden AJ
    J Nucl Med; 1976 Mar; 17(3):208-11. PubMed ID: 175138
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone uptake of 99mTc-phosphate via labeled plasma protein.
    Schümichen C; Seifritz R; Hoffmann G
    Nuklearmedizin; 1980 Aug; 19(4):174-7. PubMed ID: 6259628
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biokinetics of bone tracers by means of deconvolution analysis--comparison of 99mTc MDP, 99mTc DPD and 99mTc EHDP.
    Knop J; Stritzke P; Kröger E; Schneider C; Wasmus G
    Nuklearmedizin; 1982 Aug; 21(4):145-9. PubMed ID: 6216459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanism of localization of 99mTc-labeled pyrophosphate and tetracycline in infarcted myocardium.
    Dewanjee MK; Kahn PC
    J Nucl Med; 1976 Jul; 17(7):639-46. PubMed ID: 178842
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The influence of the method of preparation of the bone scanning agent 99mTc(Sn)EHDP on its tissue distribution in the rat.
    Van den Brand JA; Das HA; Dekker BG; de Ligny CL; Van den Hamer CJ
    Int J Appl Radiat Isot; 1982 Oct; 33(10):917-28. PubMed ID: 6818161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. 99mTc-Sn-pyrophosphate complexes, an investigation of its possible structures.
    Schümichen C; Rörvik-Schümichen K; Hoffmann G
    Nucl Med (Stuttg); 1974 Nov; 13(3):253-7. PubMed ID: 4375276
    [No Abstract]   [Full Text] [Related]  

  • 30. Technetium-99m labeled agents for skeletal imaging.
    Thrall JH
    CRC Crit Rev Clin Radiol Nucl Med; 1976; 8(1):1-31. PubMed ID: 789010
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Technetium-99m-pyrophosphate: studies in vivo and in vitro.
    Kaye M; Silverton S; Rosenthall L
    J Nucl Med; 1975 Jan; 16(1):40-5. PubMed ID: 162947
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Kinetics of various 99mTc-Sn-pyrophosphate compounds in the rat. I. In vivo studies.
    Schümichen C; Walden J; Hoffmann G
    Nuklearmedizin; 1977 Jul; 16(3):100-3. PubMed ID: 197498
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Liver uptake of 99mTc-diphosphonate.
    Chaudhuri TK
    Radiology; 1976 May; 119(2):485-6. PubMed ID: 817367
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Technical problems associated with the production of technetium Tc 99m tin(II) pyrophosphate kits.
    Kowalsky RJ; Dalton DR
    Am J Hosp Pharm; 1981 Nov; 38(11):1722-6. PubMed ID: 7304626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Uptake by bone of pyrophosphate, diphosphonates and their technetium derivatives.
    Bisaz S; Jung A; Fleisch H
    Clin Sci Mol Med; 1978 Mar; 54(3):265-72. PubMed ID: 204442
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Clinical comparison of the kinetics of 99mTc pyrophosphate and 99mTc methylene diphosphonate (author's transl)].
    Casara D; Cimitan M; Zorat P; Calzavara F
    Radiol Med; 1979; 65(1-2):67-70. PubMed ID: 223200
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 99mTc-labelled Cu(I)-EHDP, a potential skeletal imaging agent.
    Agha NH; Al-Hilli AM; Hassen HA
    Nuklearmedizin; 1981 Dec; 20(6):299-304. PubMed ID: 6799937
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmaco-kinetics of current skeletal-seeking radiopharmaceuticals.
    Krishnamurthy GT; Huebotter RJ; Tubis M; Blahd WH
    AJR Am J Roentgenol; 1976 Feb; 126(2):293-301. PubMed ID: 175699
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of DMSO treatment on the composition of 99mTc(Sn)EHDP.
    de Groot GJ; Das HA; de Ligny CL
    Int J Rad Appl Instrum A; 1986; 37(6):487-90. PubMed ID: 3019948
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of prior administration of Sn(II) complexes on in vivo distribution of 99mTc-pertechnetate.
    Khentigan A; Garrett M; Lum D; Winchell HS
    J Nucl Med; 1976 May; 17(5):380-4. PubMed ID: 1262943
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.